Details about Werner B.F. Brouwer

Access statistics for papers by Werner B.F. Brouwer.

Last updated 2009-11-06. Update your information in the RePEc Author Service.

Short-id: pbr212

Journal Articles

2009

1. Some pain, no gain: experiences with the no-claim rebate in the Dutch health care system
   Health Economics, Policy and Law, 2009, 4, (04), 405-424
2. The correction of TTO-scores for utility curvature using a risk-free utility elicitation method
   Journal of Health Economics, 2009, 28, (1), 234-243 View citations
3. The influence of subjective life expectancy on health state valuations using a 10 year TTO
   Health Economics, 2009, 18, (5), 549-558

2008

4. An Overview of Methods and Applications to Value Informal Care in Economic Evaluations of Healthcare
   PharmacoEconomics, 2008, 26, (4), 269-280
5. Can we fix it? Yes we can! But what? A new test of procedural invariance in TTO-measurement
   Health Economics, 2008, 17, (7), 877-885
6. Future costs in economic evaluation: A comment on Lee
   Journal of Health Economics, 2008, 27, (6), 1645-1649
7. Give me a break!: Informal caregiver attitudes towards respite care
   Health Policy, 2008, 88, (1), 73-87
8. The New Myth: The Social Value of the QALY
   PharmacoEconomics, 2008, 26, (1), 1-4
9. Unrelated Medical Costs in Life-Years Gained: Should They be Included in Economic Evaluations of Healthcare Interventions?
   PharmacoEconomics, 2008, 26, (10), 815-830
10. Welfarism vs. extra-welfarism
    Journal of Health Economics, 2008, 27, (2), 325-338
11. When Time is Not on Your Side: Patient Experiences with Waiting for Home Care and Admission to a Nursing or Residential Home
    The Patient: Patient-Centered Outcomes Research, 2008, 1, (1), 55-71

2007

12. Care for a break? An investigation of informal caregivers' attitudes toward respite care using Q-methodology
    Health Policy, 2007, 83, (2-3), 332-342 View citations
13. Discounting in economic evaluations: stepping forward towards optimal decision rules
    Health Economics, 2007, 16, (3), 307-317 View citations
14. Increasing tobacco taxes: A cheap tool to increase public health
    Health Policy, 2007, 82, (2), 142-152
15. Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a 'perfect' cost-utility ratio
    Health Economics, 2007, 16, (4), 421-433

2006

16. Productivity Costs in Health-State Valuations: Does Explicit Instruction Matter?
    PharmacoEconomics, 2006, 24, (4), 401-414
17. Respite care--An explorative study of demand and use in Dutch informal caregivers
    Health Policy, 2006, 78, (2-3), 194-208
18. Too Important to Ignore: Informal Caregivers and Other Significant Others
    PharmacoEconomics, 2006, 24, (1), 39-41 View citations
19. With a little help from an anchor: Discussion and evidence of anchoring effects in contingent valuation
    The Journal of Socio-Economics, 2006, 35, (5), 836-853

2005

20. Corrigendum to "Decision makers' views on health care objectives and budget constraints: results from a pilot study" [Health Policy 70 (2004) 33-48]
    Health Policy, 2005, 74, (1), 109-111
21. Economic valuation of informal care: the contingent valuation method applied to informal caregiving
    Health Economics, 2005, 14, (2), 169-183 View citations
22. Introducing Economic Evaluation as a Policy Tool in Korea: Will Decision Makers get Quality Information?: A Critical Review of Published Korean Economic Evaluations
    PharmacoEconomics, 2005, 23, (7), 709-721
23. Is silence golden? A test of the incorporation of the effects of ill-health on income and leisure in health state valuations
    Health Economics, 2005, 14, (6), 643-647
24. Measuring Productivity Changes in Economic Evaluation: Setting the Research Agenda
    PharmacoEconomics, 2005, 23, (1), 47-54
25. Process utility from providing informal care: the benefit of caring
    Health Policy, 2005, 74, (1), 85-99 View citations
26. Societal Discounting of Health Effects in Cost-Effectiveness Analyses: The Influence of Life Expectancy
    PharmacoEconomics, 2005, 23, (8), 791-802
27. The Friction-Cost Method: Replacement for Nothing and Leisure for Free?
    PharmacoEconomics, 2005, 23, (2), 105-111
28. The Relationship between Productivity and Health-Related QOL: An Exploration
    PharmacoEconomics, 2005, 23, (3), 209-218

2004

29. Decision makers' views on health care objectives and budget constraints: results from a pilot study
    Health Policy, 2004, 70, (1), 33-48 View citations
30. Discounting in decision making: the consistency argument revisited empirically
    Health Policy, 2004, 67, (2), 187-194
31. Reconciliation of Economic Concerns and Health Policy: Illustration of an Equity Adjustment Procedure Using Proportional Shortfall
    PharmacoEconomics, 2004, 22, (17), 1097-1107
32. The desire for support and respite care: preferences of Dutch informal caregivers
    Health Policy, 2004, 68, (3), 309-320
33. The influence of subjective expectations about length and quality of life on time trade-off answers
    Health Economics, 2004, 13, (8), 819-823 View citations

2003

34. Should I stay or should I go? Waiting lists and cross-border care in the Netherlands
    Health Policy, 2003, 63, (3), 289-298
35. The missing link: on the line between C and E
    Health Economics, 2003, 12, (8), 629-636 View citations

2002

36. Productivity costs before and after absence from work: as important as common?
    Health Policy, 2002, 61, (2), 173-187 View citations
37. Rationalising rationing: economic and other considerations in the debate about funding of Viagra
    Health Policy, 2002, 59, (1), 53-63

2001

38. Handbook of Health Economics
    Journal of Health Economics, 2001, 20, (5), 855-879

2000

39. On the economic foundations of CEA. Ladies and gentlemen, take your positions!
    Journal of Health Economics, 2000, 19, (4), 439-459 View citations

1999

40. Priority care for employees: A blessing in disguise?
    Health Economics, 1999, 8, (1), 65-73 View citations
41. Private clinics for employees as a Dutch solution for waiting lists: economic and legal arguments
    Health Policy, 1999, 47, (1), 1-17 View citations
42. Productivity losses without absence: measurement validation and empirical evidence
    Health Policy, 1999, 48, (1), 13-27 View citations

1998

43. An Outline For a Cost-Effectiveness Analysis of a Drug For Patients With Alzheimer's Disease
    PharmacoEconomics, 1998, 13, (1 Part 1), 21-34
44. How to Calculate Indirect Costs in Economic Evaluations
    PharmacoEconomics, 1998, 13, (5), 563-569 View citations

1997

45. Productivity Costs Measurement Through Quality of Life? A Response to the Recommendation of the Washington Panel
    Health Economics, 1997, 6, (3), 253-259 View citations
46. Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussion
    Health Economics, 1997, 6, (5), 511-514 View citations